The Problem of Incomplete Myocardial Revascularization in Percutaneous Coronary Intervention in Patients With NSTEMI
CONTRAST
1 other identifier
observational
139
1 country
1
Brief Summary
The study included all patients admitted to the intensive care unit of the district hospital and sent to the angiographic Department for diagnosis and performance of PCI with a diagnosis of NSTEMI, including myocardial infarction (mi) and unstable angina, determined by clinical data, ECG signs and laboratory indicators. Data from patients living in the Sergiev Posad municipal district will be analyzed in order to achieve maximum registration of adverse events during one year of follow-up.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Nov 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2020
CompletedFirst Submitted
Initial submission to the registry
July 24, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
July 28, 2020
CompletedFirst Posted
Study publicly available on registry
July 29, 2020
CompletedSeptember 22, 2020
September 1, 2020
1.3 years
July 24, 2020
September 21, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Time to non- fatal myocardial infarction, stroke, repeated hospitalizations for cardiovascular reasons, repeated PCI, CABG, cardiovascular death or death from all-cause
Primary Outcome Measures will be evaluated 12 months after the patient is discharged from the hospital
12 months
Study Arms (3)
complete revascularization
All patients who underwent complete myocardial revascularization
incomplete revascularization
All patients who did not complete myocardial revascularization
without revascularization
All patients who were not revascularized
Eligibility Criteria
All patients were admitted to the intensive care unit of the district hospital from November 2018 to February 2019 and sent to the angiographic Department for diagnosis and performance of PCI with a diagnosis of NSTEMI, including myocardial infarction (mi) and unstable angina, determined by clinical data, ECG signs and laboratory indicators. Data from patients living in the Sergiev Posad municipal district will be analyzed in order to achieve maximum registration of adverse events during one year of follow-up. (Included in the registry profile)
You may qualify if:
- \- All patients who were referred to an angiographic unit with a diagnosis of NSTEMI for diagnostic coronary angiography and/or PCI from November 2018 to February 2019.
You may not qualify if:
- Patients with myocardial infarction with ECG- confirmed ST elevation of more than 1 mm in two leads.
- Residents of areas other than the area in question that may be difficult to contact.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sergiyev Posad city hospital
Sergiyev Posad, Moscow Oblast, 141301, Russia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Vladimir Mazaev
National Research Center for Therapy and Preventive Medicine
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 24, 2020
First Posted
July 29, 2020
Study Start
November 1, 2018
Primary Completion
February 28, 2020
Study Completion
July 28, 2020
Last Updated
September 22, 2020
Record last verified: 2020-09
Data Sharing
- IPD Sharing
- Will not share